Evidence map›Paper›PMID 37840824›Full record

ArticleInternational journal of general medicine2023

Can Patients with Asymptomatic/Mild Illness and Moderate Illness COVID-19 Have White Matter Damage?

Cunsheng Wei, Xiaorong Yu, Yuan Chen, Tingting Yang, Shenghua Li, Junrong Li, Xuemei Chen

Open access · goldAbstract read
In one paragraph

Article in International journal of general medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Health Status and COVID-19 Epidemiology in an Inland Region of Portugal: A Retrospective Study.International journal of environmental research and public health · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Cunsheng Wei *Department of Neurology, Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, Jiangsu, 211100, People's Republic of China.
Xiaorong Yu *Department of Neurology, Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, Jiangsu, 211100, People's Republic of China.
Yuan ChenDepartment of Neurology, Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, Jiangsu, 211100, People's Republic of China.
Tingting YangDepartment of Neurology, Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, Jiangsu, 211100, People's Republic of China.
Shenghua LiDepartment of Neurology, Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, Jiangsu, 211100, People's Republic of China.
Junrong LiDepartment of Neurology, Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, Jiangsu, 211100, People's Republic of China.
Xuemei ChenDepartment of Neurology, Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, Jiangsu, 211100, People's Republic of China.
Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: Studies have shown that severe coronavirus pandemic 2019 infection could lead to white matter hyperintensities, but the relationship between asymptomatic/mild illness and moderate illness coronavirus pandemic 2019 and white matter hyperintensities remains largely unknown. This study aimed to investigate the relationship between asymptomatic/mild illness and moderate illness coronavirus pandemic 2019 and the risk of white matter hyperintensities. Methods: Hospitalized patients who were confirmed to have coronavirus pandemic 2019 for the first time were enrolled. Fazekas scores were used for assessment of the severity of white matter hyperintensities. We also rated the 90-day functional outcome after discharge. Results: Of the 157 enrolled patients, 124 (78.98%) coronavirus pandemic 2019 patients were classified as having asymptomatic or mild illness, and 33 (21.02%) were classified as having moderate illness. The results showed that the Fazekas scale scores at baseline (periventricular white matter hyperintensities, 1.31±1.16 vs 2.06±1.20; Deep white matter hyperintensities, 1.04±0.97 vs 1.73±1.13 Conclusion: Our findings suggest that moderate COVID-19 is related to severe white matter hyperintensities compared with asymptomatic/mild illness but not to the progression of white matter hyperintensities.

Indexed as

coronavirus pandemic 2019Fazekas scaleprogressionriskwhite matter hyperintensities

Identifiers

PMID37840824
PMCPMC10576465
OpenAlexW4387499315

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.